Guardant Health
AUDIT: Guardant Health: The Blood Ledger: Scaling the Illusion of Precision
Katie dissects Guardant Health's aggressive market penetration strategy, explaining how massive volume surges in the Shield liquid biopsy test secure institutional adoption despite underlying margin friction.